Nobivac Tricat Trio

Country: New Zealand

Language: English

Source: Ministry for Primary Industries

Active ingredient:

feline calici virus (attenuated); feline panleucopenia virus (attenuated); feline rhinotracheitis virus (attenuated)

Available from:

Schering-Plough Animal Health Limited

INN (International Name):

feline rhinotracheitis virus (attenuated), feline panleucopenia virus (attenuated), feline calici virus (attenuated)

Composition:

feline calici virus (attenuated) 0 vaccine; feline panleucopenia virus (attenuated) 0 vaccine; feline rhinotracheitis virus (attenuated) 0 vaccine

Therapeutic area:

Vaccine

Authorization status:

ACVM Registered

Authorization date:

2008-09-22

Summary of Product characteristics

NOBIVAC TRICAT TRIO
5 ds and 25 ds – Inlay and Labels
A010164
Page 1 of 6
NOBIVAC TRICAT TRIO
02-Apr-2021
Inlay – Front Cover
RESTRICTED VETERINARY MEDICINE
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
NOBIVAC
® TRICAT TRIO
5 [25] vials containing combined live attenuated freeze-dried feline
viral herpes virus, feline
calicivirus and feline panleucopaenia virus vaccine.
5 [25] vials of sterile diluent for reconstitution of freeze-dried
Nobivac feline vaccines.
5 X 1 DOSE
[25 X 1 DOSE]
MSD AH logo
Inlay – Inside Panels
RESTRICTED VETERINARY MEDICINE
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
NOBIVAC
® TRICAT TRIO
Live attenuated vaccine for cats.
A live freeze-dried vaccine, containing:
-
Live attenuated feline calicivirus (strain F9)
-
Live attenuated feline herpes virus type 1 (rhinotracheitis) (strain
G2620A)
-
Live attenuated feline panleucopaenia virus (strain MW-1)
It is presented as a freeze-dried pellet; each pack contains 5 or 25
single dose vials. Pack
also contains 5 or 25 corresponding 1 mL vials of diluent for
reconstitution prior to injection.
INDICATION
For active immunisation of cats from the age of 8-9 weeks onwards to:
-
reduce clinical signs caused by an infection with feline calicivirus
(FCV) and feline herpes
virus type 1 (FHV)
-
to reduce replication of feline calicivirus (FCV)
-
and to prevent clinical signs, leucopenia and shedding caused by
infection with feline
panleucopaenia virus (FPLV)
The onset of immunity is 4 weeks for FCV and FHV, and 3 weeks for FPLV
following first
vaccination.
NOBIVAC TRICAT TRIO
5 ds and 25 ds – Inlay and Labels
A010164
Page 2 of 6
NOBIVAC TRICAT TRIO
02-Apr-2021
The duration of immunity is 3 years for the FCV, FHV and FPLV
components, as confirmed
by challenge study.
DOSAGE AND ADMINISTRATION
INITIAL PROGRAMME
Two doses injected subcutaneously, at an interval of 3-4 weeks are
required. The first
vaccination is given from the age of 8-9 weeks and the second
vaccination from the age of
12 weeks. If earlier vaccination is desirab